FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1766133080> ?p ?o ?g. }

• W1766133080 abstract "Cytolytic T Lymphocytes recognize peptides derived from intracellular proteins and presented by MHC class I molecules. Most of these peptides result from the degradation of cytosolic proteins by the proteasome. The composition in s-catalytic subunits determines the type of proteasome. Until now, two proteasome types have been described. The standard proteasome (s1s2s5) is present in most cell types, while the immunoproteasome (s1is2is5i) is present in dendritic cells and in cells exposed to IFN-. Some antigenic peptides are processed differentially by the two proteasome types and thus, the set of peptides expressed at the cell surface is dependent on the type of proteasome present inside the cell. This view should be refined by the existence of other proteasome types. The s-catalytic inducible subunits are incorporated following a cooperative mechanism to form a fully immunoproteasome. Theoritically, they can also form intermediate proteasomes characterized by a mix of constitutive and inducible s-catalytic subunits. Experimentally, a heterogeneity in catalytic subunits composition was observed in rat muscle, rodent heart and in human colon and liver. The lack of catalytic subunit-specific antibodies recognizing native proteasome particles has prevented the isolation of intermediate proteasomes. Here we produced a panel of unique subunit-specific antibodies to allowing to isolate intermediate proteasomes in their native conformation. With the help of these antibodies, we identified two new types of 20S proteasome which contain only one or two catalytic immunosubunits. These intermediate proteasomes contain either s1is2s5i (double intermediate) or s1s2s5i (single intermediate). They were found in eight human tumor cell lines of different histological types. They represent 10-20% of the total proteasome content of these tumor cells. In normal human tissues, we observed high proportions of intermediate proteasomes : these represented between one-third and one-half of the proteasome content of liver, kidney, small bowel, and colon. Intermediate proteasomes were also abundant in monocyte-derived dendritic cells, mainly the proteasome s5i which represents about 40% of the proteasome content of dendritic cells. To study their function in antigen processing, we produced 293 cell lines expressing only intermediate proteasomes. When tested on fluorogenic substrates, the proteolytic activities of the intermediate proteasomes were different from those of the standard proteasome and the immunoproteasome. We identified three tumor antigens produced exclusively by the proteasome s5i (MAGE-A3271-279), or by the proteasome s1i-s5i (MAGE-A10254-262 and MAGE-C2191-200). We also studied the ability of intermediate proteasomes to produce six antigenic peptides (MAGE-C241-49, MAGE-C2336-344, MAGE-A3114-122, gp100209-217, tyrosinase369-377, Melan-A26-35) that are known to be processed differentially by the standard proteasome and the immunoproteasome. Both intermediate proteasomes showed a processing activity similar to that of the immunoproteasome with regard to all but one peptides. The latter peptide, derived from MAGE-C2336-344 and presented by HLA-A2 is produced by the double but not the single intermediate proteasome. We studied cleavage sites within precursor peptides by mass spectrometry, and observed that the intermediate proteasomes, like the immunoproteasome, were characterized by a poor ability to cleave between hydrophobic residues. Surprisingly, we also observed stronger cleavages after aspartic acids by the intermediate proteasome s5i as compared to the standard proteasome, despite the presence of subunit s1, which is classically associated with the caspase-like activity, in both proteasome types. Interesting questions for further studies will be to analyse if the modulation of proteasome content also affects other proteasome functions such as the activation of transcription factor, the production of inflammatory cytokines, or the degradation of oxidized proteins." @default.
• W1766133080 created "2016-06-24" @default.
• W1766133080 creator A5058598485 @default.
• W1766133080 date "2011-01-01" @default.
• W1766133080 modified "2023-09-27" @default.
• W1766133080 title "Identification de nouveaux types de protéasome et leur implication dans l’apprêtement de peptides antigéniques présentés par les molécules CMH de classe I" @default.
• W1766133080 hasPublicationYear "2011" @default.
• W1766133080 type Work @default.
• W1766133080 sameAs 1766133080 @default.
• W1766133080 citedByCount "0" @default.
• W1766133080 crossrefType "journal-article" @default.
• W1766133080 hasAuthorship W1766133080A5058598485 @default.
• W1766133080 hasConcept C104292427 @default.
• W1766133080 hasConcept C104317684 @default.
• W1766133080 hasConcept C147483822 @default.
• W1766133080 hasConcept C153911025 @default.
• W1766133080 hasConcept C170627219 @default.
• W1766133080 hasConcept C181199279 @default.
• W1766133080 hasConcept C185592680 @default.
• W1766133080 hasConcept C195616568 @default.
• W1766133080 hasConcept C203014093 @default.
• W1766133080 hasConcept C207936829 @default.
• W1766133080 hasConcept C27740335 @default.
• W1766133080 hasConcept C2992195973 @default.
• W1766133080 hasConcept C55493867 @default.
• W1766133080 hasConcept C79879829 @default.
• W1766133080 hasConcept C86803240 @default.
• W1766133080 hasConcept C95444343 @default.
• W1766133080 hasConcept C98539663 @default.
• W1766133080 hasConceptScore W1766133080C104292427 @default.
• W1766133080 hasConceptScore W1766133080C104317684 @default.
• W1766133080 hasConceptScore W1766133080C147483822 @default.
• W1766133080 hasConceptScore W1766133080C153911025 @default.
• W1766133080 hasConceptScore W1766133080C170627219 @default.
• W1766133080 hasConceptScore W1766133080C181199279 @default.
• W1766133080 hasConceptScore W1766133080C185592680 @default.
• W1766133080 hasConceptScore W1766133080C195616568 @default.
• W1766133080 hasConceptScore W1766133080C203014093 @default.
• W1766133080 hasConceptScore W1766133080C207936829 @default.
• W1766133080 hasConceptScore W1766133080C27740335 @default.
• W1766133080 hasConceptScore W1766133080C2992195973 @default.
• W1766133080 hasConceptScore W1766133080C55493867 @default.
• W1766133080 hasConceptScore W1766133080C79879829 @default.
• W1766133080 hasConceptScore W1766133080C86803240 @default.
• W1766133080 hasConceptScore W1766133080C95444343 @default.
• W1766133080 hasConceptScore W1766133080C98539663 @default.
• W1766133080 hasLocation W17661330801 @default.
• W1766133080 hasOpenAccess W1766133080 @default.
• W1766133080 hasPrimaryLocation W17661330801 @default.
• W1766133080 isParatext "false" @default.
• W1766133080 isRetracted "false" @default.
• W1766133080 magId "1766133080" @default.
• W1766133080 workType "article" @default.